Day 2Peripheral vascular diseaseStructural heart disease

SOLACI-SOCIME 2022 | Surgical Pulmonary Valve Replacement, by Dr. Jorge Cervantes Salazar

solaci
solaci
497
0

Read the most outstanding articles from the second day of the SOLACI-SOCIME 2022 Congress.

In this case, consult the presentation by Dr. Jorge Cervantes Salazar, entitled “Surgical Pulmonary Valve Replacement”

ago-2-cervantes-spvr

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-SOCIME 2022 | Management of entrapped equipment, by Dr. José Velazco
Next article
SOLACI-SOCIME 2022 | Treatment of STEMI with Cardiogenic Shock: PCI and MCS Selection and Timing, por el Dr. Mauricio Cohen
solaci
solaci

More articles by this author

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

Dr. Omar Tupayachi - 0
The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

Dr. Omar Tupayachi - 0
The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Dr. Juan Manuel Pérez - 0
Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Coronary revascularization before TAVI: prior PCI or conservative management?

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Other

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014)...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | CHIP-BCIS3: Impella use as support in high-risk complex PCI

Dr. Omar Tupayachi - 0
The use of percutaneous ventricular support during high-risk complex PCI has been proposed as a strategy to prevent hemodynamic deterioration in patients with severe...

ACC 2026 | ORBITA-CTO: PCI in chronic total occlusions and stable angina — the randomized trial we were missing?

Dr. Omar Tupayachi - 0
Percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) remains a topic of ongoing debate in stable angina, with persistent uncertainty regarding its role...

ACC 2026 | FAST III: vFFR vs FFR in physiology-guided revascularization of intermediate coronary lesions

Dr. Omar Tupayachi - 0
Physiological assessment of intermediate coronary lesions remains a cornerstone in decision-making for coronary revascularization. Although FFR continues to be one of the guideline-recommended references,...